Penserra Capital Management LLC Next Cure, Inc. Transaction History

Penserra Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$5.7 - $9.1 $3,591 - $5,733	-630 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$7.6 - $10.28 $114 - $154	15 Added 2.44%	630 $5,000
Q1 2021 May 13, 2021	SELL	$9.81 - $13.88 $147 - $208	-15 Reduced 2.38%	615 $6,000
Q4 2020 Feb 12, 2021	BUY	$9.47 - $12.43 $5,966 - $7,830	630 New	630 $6,000

14.6M

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $20.8M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.